R
Rong Wang
Researcher at Shandong University
Publications - 52
Citations - 1263
Rong Wang is an academic researcher from Shandong University. The author has contributed to research in topics: Medicine & Kidney disease. The author has an hindex of 13, co-authored 36 publications receiving 889 citations.
Papers
More filters
Journal ArticleDOI
Acute kidney injury in China: a cross-sectional survey
Li Yang,Guolan Xing,Li Wang,Yonggui Wu,Suhua Li,Gang Xu,Qiang He,Jianghua Chen,Menghua Chen,Xiaohua Liu,Zaizhi Zhu,Lin Yang,Xiyan Lian,Feng Ding,Yun Li,Huamin Wang,Huamin Wang,Jianqin Wang,Rong Wang,Changlin Mei,Jixian Xu,Rongshan Li,Juan Cao,Lei Zhang,Yan Wang,Jinhua Xu,Beiyan Bao,Bicheng Liu,Hongyu Chen,Shaomei Li,Yan Zha,Qiong Luo,Dongcheng Chen,Yulan Shen,Yunhua Liao,Zhengrong Zhang,Xianqiu Wang,Kun Zhang,Luojin Liu,Peiju Mao,Chunxiang Guo,Jiangang Li,Zhenfu Wang,Shoujun Bai,Shuangjie Shi,Yafang Wang,Jinwei Wang,Zhangsuo Liu,Fang Wang,Dandan Huang,Shun Wang,Shuwang Ge,Quanquan Shen,Ping Zhang,Lihua Wu,Miao Pan,Xiting Zou,Ping Zhu,Jintao Zhao,Minjie Zhou,Wenping Hu,Jing Wang,Bing Liu,Tong Zhang,Jianxin Han,Tao Wen,Minghui Zhao,Haiyan Wang +67 more
TL;DR: A nationwide, cross-sectional survey of adult patients who were admitted to hospital in 2013 in academic or local hospitals from 22 provinces in mainland China aimed to evaluate the burden of AKI and assess the availability of diagnosis and treatment and found that 1·4-2·9 million people with AKI were admitted in China in 2013.
Journal ArticleDOI
LncRNA MALAT1 is dysregulated in diabetic nephropathy and involved in high glucose-induced podocyte injury via its interplay with β-catenin.
TL;DR: It is found that MALAT1 levels were increased in kidney cortices from C57BL/6 mice with streptozocin‐induced diabetic nephropathy, and dynamically regulated in cultured mouse podocytes stimulated with high glucose, which showed a trend from rise to decline.
Journal ArticleDOI
A multicenter application and evaluation of the oxford classification of IgA nephropathy in adult chinese patients.
Caihong Zeng,Weibo Le,Zhaohui Ni,Minfang Zhang,Li-Ning Miao,Ping Luo,Rong Wang,Zhimei Lv,Jianghua Chen,Jiong Tian,Nan Chen,Xiaoxia Pan,Ping Fu,Zhang-Xue Hu,Lining Wang,Qiuling Fan,Hongguang Zheng,Dewei Zhang,Yaping Wang,Yanhong Huo,Hongli Lin,Shuni Chen,Shiren Sun,Yanxia Wang,Zhangsuo Liu,Dong Liu,Lu Ma,Tao Pan,Ai-ping Zhang,Xiaoyu Jiang,Changying Xing,Bing Sun,Qiao-ling Zhou,Wenbing Tang,Fuyou Liu,Yinghong Liu,Shaoshan Liang,Feng Xu,Qian Huang,Hongbing Shen,Jianming Wang,Yu Shyr,Sharon Phillips,Stéphan Troyanov,Agnes B. Fogo,Zhihong Liu +45 more
TL;DR: The associations of mesangial hypercellularity and tubular atrophy/interstitial fibrosis with kidney disease outcomes were confirmed, and the inclusion criteria and statistical analysis were similar to the Oxford study.
Journal ArticleDOI
The Role of the p38 MAPK Signaling Pathway in High Glucose-Induced Epithelial-Mesenchymal Transition of Cultured Human Renal Tubular Epithelial Cells
TL;DR: It is suggested that p38 MAPK may play an important role in the high glucose-induced EMT by activating AP-1 in tubular epithelial cells.
Journal ArticleDOI
Efficacy and Safety of Abelmoschus manihot for Primary Glomerular Disease: A Prospective, Multicenter Randomized Controlled Clinical Trial
Li Zhang,Ping Li,Changying Xing,Jiu-yang Zhao,Yani He,Jian-qin Wang,Xiongfei Wu,Zhangsuo Liu,Ai-ping Zhang,Hongli Lin,Xiaoqiang Ding,Ai-ping Yin,Fa-huan Yuan,Ping Fu,Li Hao,Li-Ning Miao,Ru-juan Xie,Rong Wang,Chun-hua Zhou,Guang-ju Guan,Zhao Hu,Shan Lin,Ming Chang,Miao Zhang,Li-qun He,Changlin Mei,Li Wang,Xiangmei Chen +27 more
TL;DR: A manihot is a promising therapy for patients with primary kidney disease (chronic kidney disease stages 1-2) with moderate proteinuria and cannot be generalized to those with nephrotic syndrome or reduced eGFR.